Acetazolamide

CCAAT/enhancer binding protein zeta ; Rattus norvegicus







40 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 25704766 The Molecular Mechanisms of Neural Flow Coupling: A New Concept. 2015 Nov-Dec 1
2 23462267 Inhibition of aquaporin-4 significantly increases regional cerebral blood flow. 2013 Apr 17 1
3 18648196 The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease? 2008 1
4 18812680 Dramatic disappearance of moyamoya disease-induced chorea after indirect bypass surgery. 2008 Sep 2
5 15839849 The effect of i.v. L-NG methylarginine hydrochloride (L-NMMA: 546C88) on basal and acetazolamide (Diamox) induced changes of blood velocity in cerebral arteries and regional cerebral blood flow in man. 2005 May 1
6 15891167 Regional cerebral blood flow after acetazolamide challenge in patients with dural arteriovenous fistula: simple way to evaluate intracranial venous hypertension. 2005 May 4
7 15271238 Predicting stroke risk in pediatric moyamoya disease with xenon-enhanced computed tomography. 2004 Aug 1
8 15297001 The cerebrovascular dilatation effects of olprinone, a phosphodiesterase III inhibitor, in comparison with acetazolamide--a pilot study. 2004 Sep 3
9 12552334 Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate. 2003 Apr 1
10 12679394 Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET. 2003 Apr 3
11 12734690 Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine. 2003 Jul 1
12 12924705 Evaluation of extracranial-intracranial arterial bypass function by using near-infrared spectroscopy. 2003 Aug 1
13 14660711 Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease. 2003 Dec 7
14 11711216 Nitric oxide modulates cerebral blood flow stimulation by acetazolamide in the rat cortex: a laser Doppler scanning study. 2001 Nov 23 6
15 10750364 Diaschisis and acetazolamide reactivity in brainstem infarction. 2000 Feb 2
16 9885326 Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study. 1999 Jan 1
17 9567031 [Quantification of regional cerebral blood flow at the control state and loaded with diamox using split-dose 99mTc-ECD SPECT and venous blood samples]. 1998 Feb 2
18 9574639 Cerebral blood flow measurement as an indicator for an indirect revascularization procedure for adult patients with moyamoya disease. 1998 Apr 1
19 9594490 [A study on accuracy of rCBF measurements loaded with acetazolamide based on the microsphere model using iodine-123-IMP SPECT]. 1998 Mar 3
20 9740099 Neural activation of the brain with hemodynamic insufficiency. 1998 Sep 3
21 9778191 Cerebral blood flow and cerebrovascular reserve capacity: estimation by dynamic magnetic resonance imaging. 1998 Oct 1
22 9059012 [Regional cerebral blood flow measurements at pre- and post-Diamox test using split dose 99mTc-ECD SPECT: comparison with 133Xe inhalation method and linearization correction]. 1997 Jan 2
23 9267125 [Quantitative evaluation of response at acetazolamide test using 99mTc-ECD SPECT; a trial of production of the response map]. 1997 Jun 3
24 9346426 Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method. 1997 Oct 4
25 8697460 Regional cerebral hemodynamics during re-build-up phenomenon in childhood moyamoya disease. An analysis using 99mTc-HMPAO SPECT. 1996 Mar 1
26 8800350 Assessment of the ophthalmic artery as a collateral to the cerebral circulation. A comparison of transorbital Doppler ultrasonography and regional cerebral blood flow measurements. 1996 May 2
27 8803445 [Noninvasive regional cerebral blood flow measurements at pre- and post-acetazolamide test using 99mTc-ECD]. 1996 Jul 4
28 8888232 Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. 1996 Nov 1
29 7674567 [A comparison of the cerebrovascular responses to CO2 and Diamox in patients with unilateral occlusive cerebral arteries: a H2(15)O PET study]. 1995 Jun 3
30 8558790 [A time-saving approach for quantifying regional cerebral blood flow and application to split-dose method with 123I-IMP SPECT using a single-head rotating gamma-camera]. 1995 Nov 2
31 8014687 Split dose iodine-123-IMP SPECT: sequential quantitative regional cerebral blood flow change with pharmacological intervention. 1994 Jul 1
32 8519258 Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime. 1993 May 1
33 1408085 [The value of acetazolamide provocation combined with blood flow tests in the diagnosis of ischemic cerebrovascular diseases]. 1992 Sep 27 1
34 1570062 [Cerebral blood flow reactivity to hyperventilation in children with spontaneous occlusion of the circle of willis (moyamoya disease)]. 1992 Apr 1
35 1799495 [The responses of somatosensory evoked potentials and cerebral blood flow to acetazolamide in patients with occlusive carotid disease]. 1991 Oct 2
36 2785746 Effect of acetazolamide on cerebral artery blood velocity and regional cerebral blood flow in normal subjects. 1989 2
37 3258962 Cerebrovascular hemodynamics in arteriovenous malformation complicated by normal perfusion pressure breakthrough. 1988 Mar 1
38 3263623 [133Xe-DSPECT: significance of the cerebrovascular reserve capacity for the diagnosis and therapy of chronic cerebral ischemia]. 1988 Aug 1
39 3501572 [133Xe-DSPECT: normal values of resting cerebral blood flow and reserve capacity]. 1987 Oct 3
40 3655890 The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. 1987 Oct 14